You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 117 No. 11, November 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE AMERICAN SOCIETY FOR HEAD AND NECK SURGERY
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prognostic Variables in Parotid Gland Cancer

Robert A. Frankenthaler, MD; Mario A. Luna, MD; Sang Sook Lee, MD; Kie-Kian Ang, MD, PhD; Robert M. Byers, MD; Oscar M. Guillamondegui, MD; Pat Wolf; Helmuth Goepfert, MD

Arch Otolaryngol Head Neck Surg. 1991;117(11):1251-1256.


Abstract

• We performed a retrospective review of 178 previously untreated patients with primary malignant neoplasms of the parotid gland treated at our institution between 1960 and 1985. Patients were followed up for a median of 7.5 years. Fifty-nine percent underwent surgery alone, and 40% underwent surgery and radiation therapy. Univariate and multivariate analyses established the prognostic influence of cancer stage, cancer grade, histologic type, presence of lymphatic invasion, perineural invasion, tumor size, extension beyond the parotid gland fascia, cervical adenopathy, quality of margins, and patient age and gender. Survival was influenced most by tumor grade, tumor size, presence of positive cervical lymph nodes, and facial nerve invasion. The risk of local-regional recurrence was most affected by cervical adenopathy and tumor size. Distant metastases were predicted by tumor grade and size. At last contact, 39% of patients were alive and free of disease, while 26% had died of the disease. We analyzed the optimal surgical procedure and the rationale for the selection of combined treatment.

(Arch Otolaryngol Head Neck Surg. 1991;117:1251-1256)



Author Affiliations

From the Departments of Head and Neck Surgery (Drs Frankenthaler, Byers, Guillamondegui, and Goepfert and Ms Wolf), Pathology (Drs Luna and Lee), and Radiotherapy (Dr Ang), The University of Texas M. D. Anderson Cancer Center, Houston.


Footnotes

Accepted for publication August 6, 1991.

Read before the American Society for Head and Neck Surgery, Waikaloa, Hawaii, May 9, 1991.

Reprint requests to the Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Frankenthaler).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predicting Occult Lymph Node Metastasis in Parotid Cancer
Frankenthaler et al.
Arch Otolaryngol Head Neck Surg 1993;119:517-520.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.